Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$33.32 - $40.98 $1,199 - $1,475
36 New
36 $121,000
Q3 2022

Nov 03, 2022

SELL
$46.5 - $79.14 $3,487 - $5,935
-75 Reduced 34.72%
141 $160,000
Q2 2022

Aug 05, 2022

SELL
$63.06 - $84.75 $93,644 - $125,853
-1,485 Reduced 87.3%
216 $243,000
Q1 2022

May 13, 2022

SELL
$74.15 - $99.36 $64,807 - $86,840
-874 Reduced 33.94%
1,701 $2.85 Million
Q4 2021

Feb 11, 2022

BUY
$86.01 - $102.89 $218,207 - $261,031
2,537 Added 6676.32%
2,575 $3.39 Million
Q3 2021

Nov 12, 2021

BUY
$84.7 - $96.31 $3,218 - $3,659
38 New
38 $87,000
Q4 2019

Feb 28, 2020

SELL
$48.0 - $59.55 $28,416 - $35,253
-592 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$46.64 - $55.39 $699 - $830
15 Added 2.6%
592 $31,000
Q2 2019

Jul 26, 2019

BUY
$40.81 - $52.42 $23,547 - $30,246
577 New
577 $29,000
Q1 2019

Apr 19, 2019

SELL
$36.91 - $55.7 $36,873 - $55,644
-999 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$46.5 - $53.55 $46,453 - $53,496
999 New
999 $45,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.